{
    "2020-01-17": [
        [
            {
                "time": "2019-01-08",
                "original_text": "Takeaways From The JPMorgan Healthcare Conference",
                "features": {
                    "keywords": [
                        "JPMorgan",
                        "Healthcare",
                        "Conference"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates",
                "features": {
                    "keywords": [
                        "Pharma",
                        "LLY",
                        "Dermira",
                        "Buyout",
                        "Pipeline",
                        "Regulatory"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-08",
                "original_text": "Novo Nordisk's Ozempic Gets FDA Nod for CV Risk Reduction",
                "features": {
                    "keywords": [
                        "Novo",
                        "Nordisk",
                        "Ozempic",
                        "FDA",
                        "CV",
                        "Risk",
                        "Reduction"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}